SUZHOU, China , Sept. 9, 2025 /PRNewswire/ -- ImmVira Group ("ImmVira" or the "Company") recently announced that its lead engineered exosome candidate, MVR-EX105 ("EX105") is featured in a poster presentation at the 2025 Annual Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO).

Founded in 1995, IFSO is a leading international professional organization comprising bariatric and metabolic surgeons and integrated health professionals worldwide. It is dedicated to providing optimal surgical care for obesity, improving the treatment of severely obese patients, disseminating knowledge, and fostering collaboration to establish universal standards of care. The IFSO Annual Congress is one of the most influential global conferences for the exchange of

See Full Page